Cargando…

Early Clinical Features, Time to Secondary Progression, and Disability Milestones in Polish Multiple Sclerosis Patients

Background and Objectives: Determining the clinical course of multiple sclerosis (MS) and prediction of long-term disability can be a big challenge. To determine early clinical features of MS, their influence on long-term disability progression, and time to transition from relapsing-remitting MS (RR...

Descripción completa

Detalles Bibliográficos
Autores principales: Rzepiński, Łukasz, Zawadka-Kunikowska, Monika, Maciejek, Zdzisław, Newton, Julia L., Zalewski, Paweł
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630976/
https://www.ncbi.nlm.nih.gov/pubmed/31159275
http://dx.doi.org/10.3390/medicina55060232
_version_ 1783435422242701312
author Rzepiński, Łukasz
Zawadka-Kunikowska, Monika
Maciejek, Zdzisław
Newton, Julia L.
Zalewski, Paweł
author_facet Rzepiński, Łukasz
Zawadka-Kunikowska, Monika
Maciejek, Zdzisław
Newton, Julia L.
Zalewski, Paweł
author_sort Rzepiński, Łukasz
collection PubMed
description Background and Objectives: Determining the clinical course of multiple sclerosis (MS) and prediction of long-term disability can be a big challenge. To determine early clinical features of MS, their influence on long-term disability progression, and time to transition from relapsing-remitting MS (RRMS) to secondary progressive MS (SPMS), a cohort of Polish patients was studied. Materials and Methods: We retrospectively evaluated 375 Polish MS patients based on data from available medical records. We assessed early clinical MS features and the relationship between demographics and time from disease onset to attainment of 4 and 6 points on the Expanded Disability Status Scale (EDSS), as well as time to conversion from RRMS to SPMS. Results: The differences between initial MS variants were significantly associated with gender, age at disease onset, number and type of the first symptoms, and rate of the disability accrual. Mean times from disease onset to attainment of EDSS 4 and 6 were significantly influenced by the disease variant, age at onset, gender, degree of recovery from the initial symptoms, and first inter-bouts interval. The mean time to secondary progression was significantly influenced by the number and type of the first symptoms of RRMS. Conclusions: Early clinical features of MS are important in determining the disease variant, the time to transition from RRMS to SPMS, as well as predicting the disability accumulation of patients. Despite the small differences regarding the first MS symptoms, the disability outcomes in the cohort of Polish patients are similar to other regions of the world.
format Online
Article
Text
id pubmed-6630976
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-66309762019-08-19 Early Clinical Features, Time to Secondary Progression, and Disability Milestones in Polish Multiple Sclerosis Patients Rzepiński, Łukasz Zawadka-Kunikowska, Monika Maciejek, Zdzisław Newton, Julia L. Zalewski, Paweł Medicina (Kaunas) Article Background and Objectives: Determining the clinical course of multiple sclerosis (MS) and prediction of long-term disability can be a big challenge. To determine early clinical features of MS, their influence on long-term disability progression, and time to transition from relapsing-remitting MS (RRMS) to secondary progressive MS (SPMS), a cohort of Polish patients was studied. Materials and Methods: We retrospectively evaluated 375 Polish MS patients based on data from available medical records. We assessed early clinical MS features and the relationship between demographics and time from disease onset to attainment of 4 and 6 points on the Expanded Disability Status Scale (EDSS), as well as time to conversion from RRMS to SPMS. Results: The differences between initial MS variants were significantly associated with gender, age at disease onset, number and type of the first symptoms, and rate of the disability accrual. Mean times from disease onset to attainment of EDSS 4 and 6 were significantly influenced by the disease variant, age at onset, gender, degree of recovery from the initial symptoms, and first inter-bouts interval. The mean time to secondary progression was significantly influenced by the number and type of the first symptoms of RRMS. Conclusions: Early clinical features of MS are important in determining the disease variant, the time to transition from RRMS to SPMS, as well as predicting the disability accumulation of patients. Despite the small differences regarding the first MS symptoms, the disability outcomes in the cohort of Polish patients are similar to other regions of the world. MDPI 2019-05-31 /pmc/articles/PMC6630976/ /pubmed/31159275 http://dx.doi.org/10.3390/medicina55060232 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Rzepiński, Łukasz
Zawadka-Kunikowska, Monika
Maciejek, Zdzisław
Newton, Julia L.
Zalewski, Paweł
Early Clinical Features, Time to Secondary Progression, and Disability Milestones in Polish Multiple Sclerosis Patients
title Early Clinical Features, Time to Secondary Progression, and Disability Milestones in Polish Multiple Sclerosis Patients
title_full Early Clinical Features, Time to Secondary Progression, and Disability Milestones in Polish Multiple Sclerosis Patients
title_fullStr Early Clinical Features, Time to Secondary Progression, and Disability Milestones in Polish Multiple Sclerosis Patients
title_full_unstemmed Early Clinical Features, Time to Secondary Progression, and Disability Milestones in Polish Multiple Sclerosis Patients
title_short Early Clinical Features, Time to Secondary Progression, and Disability Milestones in Polish Multiple Sclerosis Patients
title_sort early clinical features, time to secondary progression, and disability milestones in polish multiple sclerosis patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630976/
https://www.ncbi.nlm.nih.gov/pubmed/31159275
http://dx.doi.org/10.3390/medicina55060232
work_keys_str_mv AT rzepinskiłukasz earlyclinicalfeaturestimetosecondaryprogressionanddisabilitymilestonesinpolishmultiplesclerosispatients
AT zawadkakunikowskamonika earlyclinicalfeaturestimetosecondaryprogressionanddisabilitymilestonesinpolishmultiplesclerosispatients
AT maciejekzdzisław earlyclinicalfeaturestimetosecondaryprogressionanddisabilitymilestonesinpolishmultiplesclerosispatients
AT newtonjulial earlyclinicalfeaturestimetosecondaryprogressionanddisabilitymilestonesinpolishmultiplesclerosispatients
AT zalewskipaweł earlyclinicalfeaturestimetosecondaryprogressionanddisabilitymilestonesinpolishmultiplesclerosispatients